Bennett Robert M
Department of Medicine (OP09), Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA.
Rheum Dis Clin North Am. 2002 May;28(2):181-99, v. doi: 10.1016/s0889-857x(02)00002-9.
The exponential increase in pain research over the last 10 years has established fibromyalgia (FM) as a common chronic pain syndrome with similar neurophysiologic aberrations to other chronic pain states. As such, the pathogenesis is considered to involve an interaction of augmented sensory processing (central sensitization) and peripheral pain generators. The notion, that FM symptomatology results from an amplification of incoming sensory impulses, has revolutionized the contemporary understanding of this enigmatic problem and provided a more rational approach to treatment. To date, the management of FM has been mainly palliative, with the aims of reducing pain, improving sleep, maintaining function, treating psychologic distress and diminishing the impact of associated syndromes. The rapidly evolving neurophysiologic, psychophysiologic and molecular biologic basis for chronic pain states has already opened up new avenues for management which should be applicable to this difficult group of patients. Indeed, it is now possible to think about a "rational" approach to managing FM patients that was unthinkable just a few years ago.
在过去10年里,疼痛研究呈指数级增长,纤维肌痛(FM)已被确立为一种常见的慢性疼痛综合征,其神经生理异常与其他慢性疼痛状态相似。因此,其发病机制被认为涉及增强的感觉处理(中枢敏化)和外周疼痛源之间的相互作用。纤维肌痛症状源于传入感觉冲动的放大这一观念,彻底改变了当代对这一棘手问题的理解,并为治疗提供了更合理的方法。迄今为止,纤维肌痛的治疗主要是姑息性的,目的是减轻疼痛、改善睡眠、维持功能、治疗心理困扰以及减轻相关综合征的影响。慢性疼痛状态迅速发展的神经生理学、心理生理学和分子生物学基础,已经为治疗开辟了新途径,这些途径应该适用于这一困难的患者群体。事实上,现在已经可以考虑采用一种“合理”的方法来管理纤维肌痛患者,而就在几年前这还是不可想象的。